Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
Type:
Grant
Filed:
May 23, 2013
Date of Patent:
December 3, 2013
Assignees:
Helsinn Healthcare SA, Roche Palo Alto LLC
Inventors:
Giorgio Calderari, Daniele Bonadeo, Roberta Cannella, Alberto Macciocchi, Andrew Miksztal, Thomas Malefyt, Kathleen M Lee, Carmine Panuccio